**3. Conclusion**

Leishmaniasis treatment research has long been neglected. In this postgenomic era, work on leishmaniasis has accelerated, but great challenges still remain for medicinal chemists and chemical biologists—selectivity over human enzymes and efficacy over parasite life cycles. This chapter will be useful for researchers who will do *in silico* and *in vitro* studies.
